Raltegravir intensification in antiretroviral-treated patients exhibiting a suboptimal CD4+ T cell response.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Raltegravir (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 06 Mar 2013 Results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
- 10 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History